Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Inspection conducted in November 2025; Establishment Inspection Report issued b...
Transaction marks entry into global naturals market and sets up manufacturing a...
Company scores 91 out of 100; included in Sustainability Yearbook 2026 for thir...
Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million an...
Findings released ahead of Shingles Action Week show low awareness and limited ...
The acquisition includes five sites specialising in various in vitro drug discov...
Vivtex will license to Novo Nordisk select oral drug-delivery technologies and i...
Initiative positions obesity as a chronic disease and highlights role of doctor...
Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data wi...
Company secures final approval for ANDA across four strengths; cumulative USFDA...
Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based...
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustabl...
The funding coincides with the in-licensing of SLTE-1009, an anti-PACAP monoclon...
The partnership brings together a high-titre glutamine synthetase (GS) knockout ...
Event highlights intelligent automation, industry collaboration, and next-gener...
Approval covers 18 mg/3 mL prefilled pens for chronic weight management in the ...
